11 – 20 of 159
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Precision Diagnostics in Myeloid Malignancies : Development and Validation of a National Capture-Based Gene Panel
- Contribution to journal › Article
- 2023
-
Mark
The complement receptor C3AR constitutes a novel therapeutic target in NPM1-mutated AML
- Contribution to journal › Article
-
Mark
Revisiting coexisting chromosomal abnormalities in NPM1-mutated AML in light of the revised ELN 2022 classification
- Contribution to journal › Letter
-
Mark
Characterization of therapy-related acute myeloid leukemia : increasing incidence and prognostic implications
- Contribution to journal › Article
-
Mark
First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia.
- Contribution to journal › Article
- 2022
-
Mark
Regional differences in treatment and outcome for myeloma patients in Sweden : A population based Swedish myeloma register study
- Contribution to journal › Article
-
Mark
Venetoclax with intensive chemotherapy in younger patients with acute myeloid leukaemia
- Contribution to journal › Debate/Note/Editorial
-
Mark
A risk score based on real-world data to predict early death in acute promyelocytic leukemia
- Contribution to journal › Article
-
Mark
Targeting SAMHD1 with hydroxyurea in first-line cytarabine-based therapy of newly diagnosed acute myeloid leukaemia : Results from the HEAT-AML trial
- Contribution to journal › Article
- 2021
-
Mark
Hairy cell leukemia and COVID-19 adaptation of treatment guidelines
- Contribution to journal › Scientific review
